Related Experiment Video
Updated: Jan 29, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
European and US guidelines for arterial hypertension: similarities and differences
Fabio Angeli1, Gianpaolo Reboldi2, Monica Trapasso2
1Division of Cardiology and Cardiovascular Pathophysiology, Hospital S. Maria della Misericordia, Perugia, Italy.
Insights
New hypertension guidelines from Europe and the US differ significantly in diagnosis and treatment goals. Optimal blood pressure management requires balancing intensive reduction with patient safety, avoiding rigid targets.
Area of Science:
- Cardiology
- Public Health
- Clinical Guidelines
Background:
- Hypertension is a prevalent global health issue, contributing significantly to disability and mortality.
- Recent hypertension guidelines from Europe and the United States present divergent approaches to diagnosis and treatment.
- Discrepancies exist in blood pressure classification and treatment targets between European and US guidelines.
Purpose of the Study:
- To analyze and compare the key differences between recent European and US hypertension guidelines.
- To evaluate the implications of these guideline discrepancies on clinical practice and patient outcomes.
- To advocate for a personalized approach in hypertension management, prioritizing a balance between efficacy and safety.
Main Methods:
- Comparative analysis of diagnostic criteria and treatment targets outlined in European and US hypertension guidelines.
- Review of the concept of 'safety boundaries' introduced in European guidelines to prevent overtreatment.
- Appraisal of evidence supporting and opposing controversial issues within the differing guideline recommendations.
Main Results:
- European guidelines define hypertension diagnosis at 140/90 mmHg, while US guidelines use 130/80 mmHg.
- European guidelines incorporate 'safety boundaries' to mitigate risks associated with aggressive blood pressure reduction.
- Significant differences in treatment goals and thresholds necessitate careful consideration in clinical decision-making.
Conclusions:
- The contrasting hypertension guidelines may influence treatment strategies and patient outcomes.
- Rigid blood pressure targets and boundaries may not be universally applicable.
- Personalized hypertension management should focus on achieving an optimal balance between intensive blood pressure reduction and treatment safety for each patient.
Abstract:
Hypertension is one of the most common chronic diseases in adults and a leading cause of disability and mortality worldwide. Recently, new Guidelines for the diagnosis and management of hypertension have been released in Europe and in the United States, with changes regarding how to diagnose and treat the condition, and the extent to which intensive blood pressure control should be pursued. Important differences between the Guidelines exist in the classification of blood pressure levels and definition of treatment goals. Diagnosis of hypertension starts at 140/90 mmHg for the European Guidelines, and 130/80 mmHg for the US Guidelines. Besides, the European guidelines introduced the concept of "safety boundaries", consisting of BP thresholds not to be exceeded towards lower levels (120 mmHg for age < 65 years, 130 mmHg for older people) because of the fear of important adverse events associated with overtreatment. Such discrepancies can indeed have an impact on treatment attitudes and outcome incidence. Hence, we appraised facts in favor and against each of these controversial issues. In conclusion we believe that, instead of fixing rigid BP targets and boundaries, modern hypertension management should be aimed to achieve in each patient an optimal balance between intensive BP reduction and treatment safety.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Causes of Similarity-Dissimilarity Effect
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Factors Influencing Attraction III: Similarity

